newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Appoints Catherine Mackey, Ph.D., to Its Board of Directors

CAMBRIDGE, Mass., June 30, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. ("Trillium" or the "Company") (TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced the appointme